Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Current Medical Research and Opinion|December 22, 2005
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)Ronald Emkey, William Koltun, Kathleen Beusterien, et al.
Nature Communications|January 13, 2022
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemiaEarl Sands, Alan Kivitz, Wesley DeHaan, et al.
Rheumatology and Therapy|March 8, 2022
A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip OsteoarthritisAlan Kivitz, Purvi Mehra, Peter Hanson, et al.
Rheumatology and Therapy|October 18, 2016
Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension StudyAlan Kivitz, Thomas Wallace, Ewa Olech, et al.
Drugs in R&D|August 5, 2021
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized StudyPeter Hanson, Alan Kivitz, Purvi Mehra, et al.
Rheumatology and Therapy|December 7, 2017
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid ArthritisAlan Kivitz, Lydie Baret-Cormel, Hubert van Hoogstraten, et al.
RMD Open|August 4, 2023
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritisAlan Kivitz, Liangwei Wang, Ilias Alevizos, et al.
Rheumatology and Therapy|March 19, 2026
A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole PatientGurjit S Kaeley, Alan Kivitz, Philip Mease, et al.
Rheumatology and Therapy|September 17, 2024
Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE StudyAlan Kivitz, Jacques Eric Gottenberg, Martin Bergman, et al.
Rheumatology and Therapy|October 10, 2025
Neuroimmune Modulation for Drug-Refractory Rheumatoid Arthritis: Long-Term Safety and Efficacy in Patients Enrolled in a Pilot Vagus Nerve Stimulation StudyNorman B Gaylis, David Sikes, Alan Kivitz, et al.
Pageof 10